APA (7th ed.) Citation

E, S., E, E., C, R., V, M., R, A., & M, M. (2018). Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LAR. Endocrine, 61(2), 343. https://doi.org/10.1007/s12020-018-1638-9

Chicago Style (17th ed.) Citation

E, Sosa-Eroza, Espinosa E, Ramírez-Rentería C, Mendoza V, Arreola R, and Mercado M. "Treatment of Multiresistant Prolactinomas with a Combination of Cabergoline and Octreotide LAR." Endocrine 61, no. 2 (2018): 343. https://doi.org/10.1007/s12020-018-1638-9.

MLA (9th ed.) Citation

E, Sosa-Eroza, et al. "Treatment of Multiresistant Prolactinomas with a Combination of Cabergoline and Octreotide LAR." Endocrine, vol. 61, no. 2, 2018, p. 343, https://doi.org/10.1007/s12020-018-1638-9.